Top 10

Cadila Healthcare gains 3% as DCGI plays phase III trials of Covid vaccine

NEW DELHI: Shares of Cadila Healthcare climbed 3 per cent in Monday's trade after the regulatory body Drugs Controller General of India (DCGI) …

Read more

Show More

Related Articles

Back to top button